Medical Devices Startups

52 North Health develops the patented Aster platform, a portable finger-prick blood test and companion app that measures cell-based and soluble biomarkers to identify immunosuppressed patients at risk of neutropenic sepsis. It also builds digital tools for remote triaging and management of emergency cancer care, working with patients and clinicians to make emergency care safer.

4 investors

Acesion Pharma is a biotech company developing pharmaceutical treatments. This page presents its leadership team and board of directors.

4 investors

Acurable manufactures wearable acoustic sensor devices for home-based patient monitoring and chronic disease management. The AcuPebble product family uses signal processing to extract disease-related biomarkers for diagnostic and disease management purposes.

4 investors

Adaptive Biotechnologies applies the genetics of the adaptive immune system to diagnostics and therapeutics, translating immune-system data into clinical insights for clinicians and biopharma companies. Its Immune Medicine Platform is used to detect, monitor, and treat disease.

4 investors

Aer Therapeutics develops a science-driven therapeutic aimed at eliminating mucus plugs in the lungs to treat muco-obstructive lung diseases such as COPD and asthma. The company focuses on respiratory care for patients with these conditions.

4 investors

Aerin Medical develops non-invasive radiofrequency treatment systems for chronic nasal conditions, offering the VivAer stylus for nasal airway obstruction and RhinAer stylus for chronic rhinitis. The treatments are performed in doctor's offices and operating rooms using a touch-screen console that delivers temperature-controlled radiofrequency therapy.

4 investors

4 investors

Agile Devices develops the Angler, a steerable and deflectable microcatheter that lets interventional radiologists actively adjust and steer the distal tip during procedures. The device is intended to reduce device exchanges, procedure time, and risk in vascular interventions.

4 investors

AIRS Medical builds an AI platform (SwiftMR and SwiftSight) that enhances MRI image quality, accelerates scan times, and generates quantitative imaging insights across mixed-vendor MRI fleets. It serves healthcare imaging organizations, radiologists, and MRI operations teams and is compatible with scanners from Siemens Healthineers, GE HealthCare, Philips, and Canon Medical.

4 investors

Albus Health develops clinically validated monitoring technology that tracks respiratory metrics, heart rate, and cough frequency to support clinical studies. Its team includes clinicians, respiratory and sleep researchers, biomedical engineers, and computer scientists serving the clinical research and medical technology field.

4 investors

Algen Biotechnologies discovers and develops small molecule therapeutics for cancer and inflammatory diseases using CRISPR, RNAi, and machine learning to decode functional gene networks and predict drug responses.

4 investors

Alife Health develops artificial intelligence technology to modernize and personalize the in vitro fertilization (IVF) process for fertility clinics and patients.

4 investors

AliveCor develops digital health solutions focused on cardiovascular care, serving employers and healthcare payers seeking enterprise heart health platforms.

4 investors

ALKemist Bio develops immunotherapies targeting ALK-positive cancers, using chimeric antigen receptor (CAR) T cells and T cell receptor (TCR) engineered T cells to eliminate treatment-resistant tumors. The company focuses on oncology precision therapies for aggressive cancers including neuroblastoma and non-small cell lung cancer.

4 investors

Allay Therapeutics develops localized pain management technology designed to deliver several weeks of post-surgical pain relief. The company focuses on supporting patients through recovery following surgery.

4 investors

Allogene Therapeutics develops allogeneic CAR T cell therapies (AlloCAR T) for blood cancers, solid tumors, and autoimmune diseases, using off-the-shelf manufactured cell products rather than patient-derived autologous approaches. The company aims to expand CAR T treatment access through scalable manufacturing, lower costs, and faster treatment delivery.

4 investors

Alnylam is a biopharmaceutical company that supports investigator-initiated studies in therapeutic areas including transthyretin-mediated amyloidosis, acute hepatic porphyria, and primary hyperoxaluria for medical researchers and healthcare professionals.

4 investors

Altis Labs provides tools for analyzing medical imaging data to help biopharma sponsors gain insight during drug development, and supports clinicians and scientists conducting medical imaging research. The company serves the biopharmaceutical and clinical research market in the medical imaging space.

4 investors

Alveo Technologies makes a palm-sized molecular diagnostic analyzer with preloaded test cartridges that deliver on-site pathogen results in under an hour, with results sent to a smartphone. It targets point-of-need infectious disease detection, including avian influenza testing for poultry farms and workers.

4 investors

Ambagon develops small molecule stabilizers of 14-3-3 protein complexes to modulate disease-related protein interactions, targeting therapeutic areas including cancer, metabolic disorders, neurodegenerative and infectious diseases.

4 investors

Antares Therapeutics discovers and develops precision medicines, with a focus on small molecule therapies targeting previously undruggable oncology targets and other serious diseases. The company combines proprietary chemistry, target biology, and predictive sciences to advance drug candidates for cancer and other therapeutic areas.

4 investors

Avvio Medical develops Microbubble SonoLithotripsy, a minimally invasive outpatient procedure that uses low-intensity ultrasound to break down ureteral stones without requiring general anesthesia or stents. The technology is designed for clinical-stage development and aims to reduce treatment wait times and expand access to stone care in various clinical settings.

4 investors

Apreo Health develops a bronchoscopic treatment for severe emphysema using a self-expanding airway scaffold designed to reduce trapped air and improve lung function. The company targets patients with severe emphysema who have limited treatment options.

4 investors

Aqtual is a precision medicine company led by experienced healthcare professionals, entrepreneurs, and technical experts.

4 investors